Nobel to Big Pharma

@Ekspert
Show original
The award on physiology and medicine of 2023 opens new prospects before technology tested in a pandemic RNA therapy which only two pharmaceutical companies in the world "Nobel Prize on physiology and medicine of 2023 own it is possible to call fayzerovsky. — the head of the laboratory of genomic engineering of MIPT Pavel Volchkov speaks. — It was handed over by two scientists who Biopharmaceutical New Technologies participated in work of companies that together with Pfizer, Inc created a mass vaccine from Koronavirus. It is impossible to tell that only works of the Nobel winners led to creation of this vaccine. But global political...
Analysis
×
Pavel Volchkov
Last position: Head of the laboratory of genomic engineering (MIPT)
Ugur Shakhin
Last position: Founder, CEO (BioNTech SE)
Vaysman Dryu
Meloun U.
Grdzelishvili Valery
MIPT
Main activity:Science and education
170
Pennsylvanian university
Main activity:Science and education
Merck KGaA
Main activity:Health care and social services
12
BioNTech SE
Main activity:Health care and social services
Twitter
Products
53